Related Experiment Video
Updated: Nov 7, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Defeating Paediatric Tuberculous Meningitis: Applying the WHO "Defeating Meningitis by 2030: Global Roadmap"
Robindra Basu Roy1,2, Sabrina Bakeera-Kitaka3, Chishala Chabala4
1Clinical Research Department, Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK.
Tackling childhood tuberculous meningitis (TBM) requires integrating tuberculosis and meningitis programs. Adapting the WHO
Area of Science:
- Pediatric infectious diseases
- Neurology
- Public health policy
Background:
- Childhood tuberculous meningitis (TBM) presents unique challenges at the intersection of tuberculosis and meningitis programs.
- Existing programs may not fully address the specific needs of children with TBM and their families.
- A coordinated approach is necessary to effectively combat TBM in pediatric populations.
Purpose of the Study:
- To adapt the World Health Organization's (WHO) "Defeating Meningitis by 2030: global roadmap" for the specific context of childhood TBM.
- To outline key goals and activities for defeating TBM in children.
- To highlight the need for integrated strategies across TB and meningitis initiatives.
Main Methods:
- A narrative review of existing literature and WHO roadmaps.
- Application of the WHO "Defeating Meningitis by 2030" roadmap's five pillars to TBM in children.
- Analysis of how prevention, diagnosis, treatment, surveillance, support, and advocacy can be tailored for TBM.
Main Results:
- The WHO roadmap's five pillars provide a framework adaptable to childhood TBM.
- Specific strategies are needed within each pillar to address TBM's unique aspects.
- Integration of TB and meningitis programs is crucial for comprehensive care.
Conclusions:
- Greater integration between meningitis and tuberculosis programs is essential at global and national levels.
- Tailoring global meningitis strategies to pediatric TBM can improve outcomes.
- A unified approach is vital for defeating childhood TBM by 2030.
More Related Videos
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Microorganisms in Medicine and Therapeutics